Advertisement

MMW - Fortschritte der Medizin

, Volume 156, Issue 4, pp 54–56 | Cite as

Maßnahmen zur Förderung der Therapie-Adhärenz

Arterielle Hypertonie
  • Christian AlbusEmail author
  • J. Matthes
FORTBILDUNG_SEMINAR

Eine medikamentöse Non-Adhärenz ist bei Hypertonie häufig und relevant für die Prognose. Erfolgversprechende Ansätze zur Verbesserung der Therapietreue sind v. a. eine Optimierung der Arzt-Patienten-Kommunikation, die Vereinfachung des Dosierungsschemas, Blutdruck-Selbstmonitoring, regelmäßige Verlaufstermine und eine Hypertonie-Schulung.

Keywords - Interventions to enhance adherence to medication

Hypertension adherence shared decision making interventions 

Literatur

  1. 1.
    Calhoun DA, Jones D, Textor S, Goff DC, Murphy TP, Toto RD, White A, Cushman WC, White W, Sica D, Ferdinand K, Giles TD, Falkner B, Carey RM. Resistant hypertension: Diagnosis, evaluation and treatment. A scientific statement from the American Heart Association professional education committee of the council for high blood pressure research. Circulation 2008;117:e510–e526.PubMedCrossRefGoogle Scholar
  2. 2.
    Osterberg L, Blaschke T. Adherence to medication. N Engl J Med 2005;353(5):487–97.PubMedCrossRefGoogle Scholar
  3. 3.
    Ho PM, Bryson CL, Rumsfeld JS. Medication adherence: its importance in cardiovascular outcomes. Circulation 2009;119(23):3028–35.PubMedCrossRefGoogle Scholar
  4. 4.
    Dunbar J. Adherence measures and their utility. Control Clin Trials 1984;5(4 Suppl):515–21.PubMedCrossRefGoogle Scholar
  5. 5.
    World Health Organisation. Adherence to long term therapies: evidence for action. 2003Google Scholar
  6. 6.
    Burnier M, Schneider MP, Chioléro A, Stubi CL, Brunner HR. Electronic compliance monitoring in resistant hypertension: the basis for rational therapeutic decisions. J Hypertens 2001; 19: 335–41PubMedCrossRefGoogle Scholar
  7. 7.
    General Medical Council. Consent: patients and doctors making decisions together. 2008Google Scholar
  8. 8.
    Perk J, De Backer G, Gohlke H, Graham I, Reiner Z, Verschuren M, Albus C, Benlian P, Boysen G, Cifkova R, Deaton C, Ebrahim S, Fisher M, Germano G, Hobbs R, Hoes A, Karadeniz S, Mezzani A, Prescott E, Ryden L, Scherer M, Syvänne M, Scholte op Reimer WJ, Vrints C, Wood D, Zamorano JL, Zannad F. European guidelines on cardiovascular disease prevention in clinical practice (version 2012). Eur Heart J 2012 (Epub ahead of print)Google Scholar
  9. 9.
    Conn VS, Hafdahl AR, Cooper PS, Ruppar TM, Mehr DR, Russell CL. Interventions to improve medication adherence among older adults: meta-analysis of adherence outcomes among randomized controlled trials. The Gerontologist 2009;49:447–62.PubMedCrossRefGoogle Scholar
  10. 10.
    Kripalani S, Yao X, Haynes RB. Interventions to enhance medication adherence in chronic medical conditions. A systematic review. Arch Int Med 2007;167:540–50.CrossRefGoogle Scholar
  11. 11.
    Mancia G, Fagard R, Narkiewsz K, Redon J, Zanchetti A, Böhm M, Christaens T, Cifkova R, De Backer G, Dominicak A, Galderesi M, Grobbee DE, Jaarsma T, Kirchhof P, Kjedsen SE, Laurant S, Manolis AJ, Nilsson PM, Ruilope LM, Schmieder RE, Sirnes PA, Sleight P, Viigimaa M, Waeber B, Zannad F. 2013 ESH/ ESC guidelines for the management of arterial hypertension. J Hypertension 2013;31:1281–1357.CrossRefGoogle Scholar
  12. 12.
    Matthes J, Albus C. Improving adherence with medication - a selective literature review based on the example of hypertension treatment. Dtsch Arzteblatt Int 2014; III:41–7Google Scholar

Copyright information

© Urban & Vogel 2014

Authors and Affiliations

  1. 1.Klinik und Poliklinik für Psychosomatik und PsychotherapieUniversitätsklinikum KölnKölnDeutschland

Personalised recommendations